captopril has been researched along with bmy 7378 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Anselmi, E; D'Ocon, P; Gisbert, R; Ivorra, MD; Miquel, R; Noguera, MA; Ziani, K | 1 |
| Gallardo-Ortíz, IA; Godínez-Hernández, D; López-Sánchez, P; Villalobos-Molina, R | 1 |
3 other study(ies) available for captopril and bmy 7378
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Pathological role of a constitutively active population of alpha(1D)-adrenoceptors in arteries of spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Age Factors; Animals; Antihypertensive Agents; Aorta, Thoracic; Arteries; Captopril; Dose-Response Relationship, Drug; Hemodynamics; Hypertension; Iliac Artery; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Piperazines; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-1; Tail; Vasoconstriction; Vasodilation | 2002 |
Captopril therapy decreases both expression and function of alpha-adrenoceptors in pre- hypertensive rat aorta.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Captopril; Dose-Response Relationship, Drug; Hypertension; Male; Muscle, Smooth, Vascular; Phenylephrine; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-1; Vasoconstriction | 2006 |